PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Czasopismo
2010 | 8 | 4 | 834-841
Tytuł artykułu

Inclusion complexes of amlodipine besylate and cyclodextrins

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
In this paper the procedure for the preparation of inclusion complexes of amlodipine besylate with β-cyclodextrin (β-CD) and 2-hydrohypropyl-β-cyclodextrin (HPβ-CD) and their structural characterization was described. Molecular inclusion complexes of amlodipine besylate are prepared by the coprecipitation method and characterised by the application of spectroscopic methods FTIR, 1H-NMR and XRD. The photosensitivity of amlodipine besylate in the inclusion complexes was also determined with respect to uncomplexed agent. DSC curves indicate the loss of the clear peak due to melting of amlodipine besylate at about 200°C, while on XR diffractograms certain reflections are lost belonging to amlodipine besylate in complexes. This indicates its inclusion in the vacancies of the host. The inclusion of amlodipine besylate with cyclodextrins increases the stability, i.e. decreases the photosensitivity of amlodipine besylate. [...]
Wydawca

Czasopismo
Rocznik
Tom
8
Numer
4
Strony
834-841
Opis fizyczny
Daty
wydano
2010-08-01
online
2010-06-17
Twórcy
autor
  • Faculty of Sciences, Department of Physics, University of Novi Sad, 21000, Novi Sad, Serbia, akapor@df.uns.ac.rs
  • Faculty of Technology, University of Nis, 16000, Leskovac, Serbia
  • Faculty of Technology, University of Nis, 16000, Leskovac, Serbia
  • Faculty of Technology, University of Nis, 16000, Leskovac, Serbia
  • Faculty of Technology, University of Nis, 16000, Leskovac, Serbia
  • Faculty of Technology, University of Nis, 16000, Leskovac, Serbia
  • Faculty of Technology, University of Nis, 16000, Leskovac, Serbia
Bibliografia
  • [1] J. Stressnig, M. Grabner, J. Mitterdorfer, S. Hering, M. Sinnegger, H. Glossmann, Trends Pharmacol. Sci. 19, 108 (1998) http://dx.doi.org/10.1016/S0165-6147(98)01171-7[Crossref]
  • [2] D.R. Ambernethy, Am. Heart J. 118, 1100 (1989) http://dx.doi.org/10.1016/0002-8703(89)90834-X[Crossref]
  • [3] P.A. Meredith, H.L. Elliott, Clin. Pharmacokinet. 22, 22 (1992) http://dx.doi.org/10.2165/00003088-199222010-00003[Crossref]
  • [4] E.M. Sorkin, S.P. Clissold, Drugs 33, 296 (1987) http://dx.doi.org/10.2165/00003495-198733040-00002[Crossref]
  • [5] D. Murdoch, R.C. Heel, Drugs 41, 478 (1991) http://dx.doi.org/10.2165/00003495-199141030-00009[Crossref]
  • [6] J. Yoshida, T. Ishibashi, M. Nishio, Eur. J. Pharmacol. 472, 23 (2003) http://dx.doi.org/10.1016/S0014-2999(03)01831-4[Crossref]
  • [7] J. Yoshida, T. Ishibashi, M. Nishio, Eur. J. Pharmacol. 492, 103 (2004) http://dx.doi.org/10.1016/j.ejphar.2004.04.006[Crossref]
  • [8] X. Li, G.R. Ruan, W.L. Lu, H.Y. Hong, G.W. Liang, Y.T. Zhang, Y. Liu, C. long, X. Ma, L. Yuan, J.C. Wang, X. Zhang, Q. Zhang, Journal of Controlled Release 112, 186 (2006) http://dx.doi.org/10.1016/j.jconrel.2006.01.007[Crossref]
  • [9] G. Ragno, A. Garofalo, C. Vetuschi, J. Pharm. Biomed. Anal. 27, 19 (2002) http://dx.doi.org/10.1016/S0731-7085(01)00556-8[Crossref]
  • [10] G. Ragno, E. Cione, A. Garofalo, G. Genchi, G. Ioele, A. Risoli, A. Spagnoletta, Int. J. Pharm. 265, 125 (2003) http://dx.doi.org/10.1016/j.ijpharm.2003.07.001[Crossref]
  • [11] A. Michelitsch, J. Reiner, M. Schubert-Zsilavecz, W. Likussar, Pharmazie 50, 548 (1995)
  • [12] V. Nikolić, Lj. Nikolić, M. Stanković, A. Kapor, M. Popsavin, D. Cvetković, J. Serb. Chem. Soc. 72, 737 (2007) http://dx.doi.org/10.2298/JSC0709737N[Crossref]
  • [13] V. Nikolić, M. Stanković, A. Kapor, Lj. Nikolić, D. Cvetković, J. Stamenković, Pharmazie 59, 845 (2004)
  • [14] T. Cserhati, E. Forgacs, J. Szejtli, Int. J. Pharm. 141, 1 (1996) http://dx.doi.org/10.1016/0378-5173(96)04583-8[Crossref]
  • [15] K. Csabai, M. Vikmon, J. Szejtli, E. Redenti, G. Poli, P. Vrntura, J. Inclusion Phenom. Macromol. Chem. 31, 169 (1998) http://dx.doi.org/10.1023/A:1007959417684[Crossref]
  • [16] R.H. Bisby, C. Mead, C.G. Morgan, Photochem. Photobiol. 71, 57 (2000) http://dx.doi.org/10.1562/0031-8655(2000)072<0057:AUODIP>2.0.CO;2[Crossref]
  • [17] P. Sansdrap, A.J. Moë, Int. J. Pharm. 98, 157 (1993) http://dx.doi.org/10.1016/0378-5173(93)90052-H[Crossref]
  • [18] N. Yüksel, T. Tincer, T. Baykara, Int. J. Pharm. 140, 145 (1996) http://dx.doi.org/10.1016/0378-5173(96)04560-7[Crossref]
  • [19] J. Mielcarek, A. Czernielewska, B. Czarczynska, J. Incl. Phenom. Macro. 54, 17 (2006) http://dx.doi.org/10.1007/s10847-005-2603-9[Crossref]
  • [20] A. Kapor, S. Skuban, V. Nikolić, Ž. Cvejić, S. Rakić, J. Res. Phys. Vol. 32, No.1, 25 (2008)
  • [21] V. Marinković, D. Agbaba, K. Karljiković-Rajić, J. Comor, D. Živanov-Stakić, Il Farmaco 55, 128 (2000) http://dx.doi.org/10.1016/S0014-827X(00)00004-5[Crossref]
  • [22] J. Mielcarek, J. Pharm. Biomed. Anal. 15, 681 (1997) http://dx.doi.org/10.1016/S0731-7085(96)01900-0[Crossref]
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_s11532-010-0061-8
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.